Symptomatic lumbar spinal stenosis Musculoskeletal Diseases
Conditions
Interventions
The BOOST programme has been published in detail and is described in brief below.
Dose and method: BOOST is predominantly a group-based intervention. It consists of one 60-minute individual session f
Sponsors
University of Exeter
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient participants: 1. Able to give informed consent 2. Aged 65 years and over 3. Symptoms consistent with symptomatic lumbar spinal stenosis: 3.1. A report of back pain and/or pain or other symptoms such as tingling, numbness or heaviness that travels from their back into their buttocks or legs in the last 6 weeks. 3.2. Standing or walking makes symptoms in the buttocks or legs worse. 3.3. Sitting or bending forward relieves symptoms. Therapist participants: 1. Be either a qualified a health professional or a level 4 exercise therapist. 2. Provide treatment (or plan to provide treatment in the near future) to patients with symptomatic lumbar spinal stenosis. 3. Be based in the UK. 4. Employed by either the NHS or a community health provider (depending on local business models, exercise therapists can be self-employed if they are providing services for a community provider). 5. Aged 21 years and over.
Exclusion criteria
Exclusion criteria: Patient participants: 1. Nursing home resident. 2. Inability to walk 3 meters independently. 3. Awaiting surgery. 4. Cauda equina syndrome or signs of serious pathology. 5. Cognitive impairment (defined as a score of 6 or lower on the Abbreviated Mental Test score.) 6. Registered blind. 7. Unable to follow instructions in a group setting. Therapist participants: Not meeting the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Walking capacity is measured using the patient-reported Oswestry Disability Index (ODI) walking item and the objective 6 minute walk test at baseline and at 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain related disability is measured by the ODI at baseline and at 6 months 2. Health related quality of life is measured by the EQ-5D-5L at baseline and at 6 months 3. Troublesomeness is measured using a single item measuring how troublesome back and leg symptoms have been over the past 4 weeks at baseline and at 6 months 4. Satisfaction is measured at 6 months 5. Physical activity is measured using 4 items from the physical activity and sedentary behaviour questionnaire (CSEP-PATH) at baseline and at 6 months 6. Activity measured from a wrist worn accelerometer will be measured over 16-days at baseline and at 6 months 7. Sleep efficacy will be measured from a wrist worn accelerometer will be measured over 16-days at baseline and at 6 months | — |
Countries
England, United Kingdom
Outcome results
None listed